Macroaxis: Personalized Investing
Simple Personalized Investing

JNJ PFE NVS SNY Realty Aggressive Healthcare Funds Diversified Assets 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for BSPM

Biostar news

 
 Companies |  Insiders  | Dashboard  
  
Add To Portfolio  add BSPM to portfolio
   

Biostar Pharmaceuticals

Stock@NASDAQ General Markets 
United States USD
     
Use Biostar Pharmaceuticals Inc news together with your stock portfolios to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.  Suggest Portfolio
View Biostar Timeline

    
  
Few days ago at www.businesswire.com         
Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for ...
The study was sponsored by Kona Medical Inc. Currently the clinical sites are enrolling and treating ... The company was founded in 2009 and its investors include Essex Woodlands Domain Associates Morgenthaler Ventures and BioStar Ventures. About ...
Check History
Focus
  
  
Few days ago at www.healthpointcapital.com         
Musculoskeletal News Roundup 17May13
Trice Orthopedics Inc. raised 3.0 million in Series A round of financing led by BioStar Ventures and Millennium Fund of Santa Clara.
Check History
Focus
  
  
Few days ago at seekingalpha.com         
Biostar Pharmaceutical CEO Discusses Q1 2013 Results Earnings Call ...
Biostar Pharmaceuticals Inc. Q1 2013 Earnings Call May 16 2013 900 AM ET. Operator. Ladies and gentlemen thank you for standing and welcome to the Biostar Pharmaceuticals Incorporated First Quarter 2013 Earnings Conference Call.
Check History
Focus
  
  
Few days ago at www.sacbee.com         
Biostar Pharmaceuticals Inc. Announces First Quarter 2013 Financial Results
Biostar Pharmaceuticals Inc. through its wholly owned subsidiary and controlled affiliate in China develops manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions.
Check History
Focus
  
  
Few days ago at www.news-medical.net         
Biostar Pharmaceuticals revenue decreases 23.9 to 12.1 million in first ...
Biostar Pharmaceuticals Inc. a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions today announced financial results ...
Check History
Focus
  
  
Few days ago at www.nasdaq.com         
Biostar Pharmaceuticals Q1 13 Earnings Conference Call At 900 AM ET
Biostar Pharmaceuticals Inc. will host a conference call at 900 AM ETMay 16 2013 to discuss its Q1 13 earnings results.
Check History
Focus
  
  
Few days ago at online.wsj.com         
Biostar Pharmaceuticals Inc. Announces First Quarter 2013 Financial Results
Wall Street Journal May 16 2013 XIANYANG China May 16 2013 PRNewswire Biostar Pharmaceuticals Inc. a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of ...
Check History
Focus
  
  
Few days ago at www.dailymarkets.com         
Biostar Pharmaceuticals Inc. Announces First Quarter 2013 Financial Results
Daily Markets May 16 2013 XIANYANG China May 16 2013 PRNewswire Biostar Pharmaceuticals Inc. a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of ...
Check History
Focus
  
  
Few days ago at www.4-traders.com         
BIOSTAR PHARMACEUTICALS INC. Biostar Pharmaceuticals Inc. to Host ...
Biostar Pharmaceuticals Inc. through its wholly owned subsidiary and controlled affiliate in China develops manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions.
Check History
Focus
  
  
Few days ago at www.prnewswire.com         
Biostar Pharmaceuticals Inc. to Host Fiscal Year 2013 First Quarter Earnings ...
PR Newswire May 14 2013 XIANYANG China May 14 2013 PRNewswire Biostar Pharmaceuticals Inc. a PRCbased manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of ...
Check History
Focus
  
  
Few days ago at www.fiercebiotech.com         
AltheRx Pharma adds 15M new CEO and exAstraZeneca exec
After gaining its lead asset from GlaxoSmithKline AltheRx Pharmaceuticals has made a series of leadership changes through a restructuring plan that features a 15 million investment led by Becker Ventures.
Check History
Focus
  
  
Few days ago at www.fiercebiotech.com         
AltheRx Pharmaceuticals Raises 15 Million Names Jim Bennethum Chief ...
Exton PA May 2 2013 AltheRx Pharmaceuticals a privatelyheld clinical development company today announced a restructuring that includes a 15 million financing the appointment of Jim Bennethum as Chief Executive Officer and the ...
Check History
Focus
  
  
Few days ago at online.wsj.com         
AltheRx Pharmaceuticals Raises 15 Million Names Jim Bennethum Chief ...
Wall Street Journal May 2 2013 AltheRx Pharmaceuticals a privatelyheld clinical development company today announced a restructuring that includes a 15 million financing the appointment of Jim Bennethum as Chief Executive Officer and the appointment of a new Board of ...
Check History
Focus
  
  
Few days ago at www.pehub.com         
AltheRx Pharmaceuticals Inks 15M
Private Equity Hub May 2 2013 Posted on May 02 2013. Clinical development company AltheRx Pharmaceuticals has announced a restructuring which includes 15 million in fresh capital and has also named Jim Bennethum as chief executive officer.
Check History
Focus
  
  
Few days ago at www.dailymarkets.com         
Asia Carbon Industries Inc. Announces Its Appointment Of New Chief Financial ...
Daily Markets Apr 29 2013 From July 2007 to June 2010 Ms. Zhao served as chief financial officer for Biostar Pharmaceuticals Inc. a public company with its securities trading on NASDAQ.
Check History
Focus
  
    

Biostar Revenue

Biostar Pharmaceuticals Inc is rated below average in revenue category among related companies. Market size based on revenue of Drug Manufacturers - Major industry is currently estimated at about 384.41 Billion. Biostar adds roughly 49.32 Million in revenue claiming only tiny portion of equities under Drug Manufacturers - Major industry.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog

Biostar Research Report

   
Generate Report

Biostar vs. Johnson

Correlation analysis and fundamentals comparison between Biostar Pharmaceuticals and Johnson Johnson
Correlation
Fundamentals

Biostar Total Debt

Based on latest financial disclosure Biostar Pharmaceuticals Inc has Total Debt of 4.76 M. This is 99.69% lower than that of Healthcare sector, and 99.92% lower than that of Drug Manufacturers - Major industry, The Total Debt for all stocks is 99.91% higher than the company.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
More...
Follow Biostar News with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add Biostar to your reader
Syndicate
 
 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium